EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.1 USD | -0.07% |
|
+3.06% | +18.16% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 9 M€ | +10.60% | ||
| 0.09% | 571 M€ | +8.36% | - | |
| 0.09% | 0 M€ | 0.00% | - | |
| 0.08% | 1,166 M€ | +0.26% | - | |
| 0.08% | 607 M€ | +0.05% | - | |
| 0.08% | 34 M€ | +9.13% | - | |
| 0.07% | 391 M€ | +9.47% | - | |
| 0.06% | 306 M€ | +6.92% | - | |
| 0.06% | 39 M€ | +6.61% | - | |
| 0.06% | 7 M€ | +6.78% | - | |
| 0.06% | 32 M€ | +2.08% | - | |
| 0.06% | 17 M€ | +6.77% | - | |
| 0.05% | 45 M€ | 0.00% | - | |
| 0.05% | 15 M€ | -1.62% | - | |
| 0.04% | 17 M€ | +3.30% | - | |
| 0.04% | 9 M€ | +10.70% | - | |
| 0.04% | 17 M€ | +4.99% | - | |
| 0.03% | 105 M€ | +4.11% | - | |
| 0.03% | 6 M€ | +3.89% | ||
| 0.03% | 32 M€ | +2.19% | - | |
| 0.02% | 6 M€ | -4.26% | - | |
| 0.02% | 8 M€ | +1.26% | - | |
| 0.02% | 756 M€ | +1.26% | - | |
| 0.02% | 2 M€ | +3.16% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
24/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.11
USD
Average target price
95.9
USD
Spread / Average Target
+6.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.16% | 54.33B | |
| +12.50% | 229B | |
| +14.52% | 195B | |
| +17.51% | 142B | |
| +28.96% | 109B | |
| +3.27% | 64.85B | |
| +7.63% | 52.09B | |
| +10.95% | 45.15B | |
| +5.10% | 37.39B | |
| +27.85% | 32.41B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
